Market Research Logo

Global Idiopathic Thrombocytopenic Purpura Therapeutics Market 2019-2023

Global Idiopathic Thrombocytopenic Purpura Therapeutics Market 2019-2023

About Idiopathic Thrombocytopenic Purpura

Platelets are the blood cells that help to stop bleeding. Idiopathic thrombocytopenic purpura (ITP) is caused due to abnormal decrease in the platelet count. This disease is also called immune thrombocytopenic purpura.

Technavio’s analysts forecast the Global Idiopathic Thrombocytopenic Purpura Therapeutics Market to grow at a CAGR of 5.41% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the idiopathic thrombocytopenic purpura therapeutics market. To calculate the market size, the report considers the revenue generated from the application of idiopathic thrombocytopenic purpura therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, idiopathic thrombocytopenic purpura therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Amgen
  • Bristol-Myers Squibb
  • Eisai
  • Merck Sharp & Dohme
  • Novartis
Market driver
  • Increasing second- and third-line therapies.
  • For a full, detailed list, view our report
Market challenge
  • Side effects of approved treatment
  • For a full, detailed list, view our report
Market trend
  • Development of combination therapy for ITP
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global rare disease market
      • Table Segments of global rare disease market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Biologics - Market size and forecast 2018-2023
      • Table Biologics - Market size and forecast 2018-2023 ($ millions)
      • Table Biologics - Year-over-year growth 2019-2023 (%)
    • Small molecules - Market size and forecast 2018-2023
      • Table Small molecules - Market size and forecast 2018-2023 ($ millions)
      • Table Small molecules - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customr landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
    • Table Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Molecules in late-stage development in 2017-2018
      • Table Recent approvals
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Amgen
      • Table Amgen - Vendor overview
      • Table Amgen - Business segments
      • Table Amgen - Organizational developments
      • Table Amgen - Segment focus
      • Table Amgen - Geographic focus
      • Table Amgen - Key offerings
      • Table Amgen - Key customers
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb - Vendor overview
      • Table Bristol-Myers Squibb - Business segments
      • Table Bristol-Myers Squibb - Organizational developments
      • Table Bristol-Myers Squibb - Segment focus
      • Table Bristol-Myers Squibb - Geographic focus
      • Table Bristol-Myers Squibb - Key offerings
      • Table Bristol-Myers Squibb - Key customers
    • Eisai
      • Table Eisai - Vendor overview
      • Table Eisai - Business segments
      • Table Eisai - Organizational developments
      • Table Eisai - Segment focus
      • Table Eisai - Geographic focus
      • Table Eisai - Key offerings
      • Table Eisai - Key customers
    • Merck Sharp & Dohme
      • Table Merck Sharp & Dohme - Vendor overview
      • Table Merck Sharp & Dohme - Business segments
      • Table Merck Sharp & Dohme - Organizational developments
      • Table Merck Sharp & Dohme - Segment focus
      • Table Merck Sharp & Dohme - Geographic focus
      • Table Merck Sharp & Dohme - Key offerings
      • Table Merck Sharp & Dohme - Key customers
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Segment focus
      • Table Novartis - Geographic focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques: Market sizing Applied
    • List of abbreviations
      • Table List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report